Targeted next generation sequencing is a universal tool for non-invasive diagnosis of fetal platelet antigens in fetal and neonatal alloimmune thrombocytopenia - Research portal of Justus Liebig University Giessen:

Meeting Abstract

Targeted next generation sequencing is a universal tool for non-invasive diagnosis of fetal platelet antigens in fetal and neonatal alloimmune thrombocytopenia

Authors list: Wienzek-Lischka, S.; Froehner, V; Krautwurst, A.; Dehl, J.; Gattenloehner, S.; Braeuninger, A.; Deisting, C.; Axt-Fliedner, R.; Degenhardt, J.; Santoso, S.; Sachs, U.; Bein, G.

Publication year: 2017

Pages: 2-2

Journal: Transfusion Medicine and Hemotherapy

Volume number: 44

ISSN: 1660-3796

eISSN: 1660-3818

Publisher: Karger Publishers

Citation Styles

Harvard Citation style: Wienzek-Lischka, S., Froehner, V., Krautwurst, A., Dehl, J., Gattenloehner, S., Braeuninger, A., et al. (2017) Targeted next generation sequencing is a universal tool for non-invasive diagnosis of fetal platelet antigens in fetal and neonatal alloimmune thrombocytopenia, Transfusion Medicine and Hemotherapy, 44, p. 2

APA Citation style: Wienzek-Lischka, S., Froehner, V., Krautwurst, A., Dehl, J., Gattenloehner, S., Braeuninger, A., Deisting, C., Axt-Fliedner, R., Degenhardt, J., Santoso, S., Sachs, U., & Bein, G. (2017). Targeted next generation sequencing is a universal tool for non-invasive diagnosis of fetal platelet antigens in fetal and neonatal alloimmune thrombocytopenia. Transfusion Medicine and Hemotherapy. 44, 2.